HL7 Electronic Health Record System Functional Model, Release 2.1.1
2.1.1 - Normative

HL7 Electronic Health Record System Functional Model, Release 2.1.1, published by HL7 International / Electronic Health Records. This guide is not an authorized publication; it is the continuous build for version 2.1.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ehrsfm-ig/ and changes regularly. See the Directory of published versions

## Requirements: CP.4.5 Manage Orders for Blood Products and Other Biologics (Function)

Official URL: http://hl7.org/ehrs/uv/ehrsfmr2/Requirements/EHRSFMR2-CP.4.5 | Version: 2.1.1
Standards status: Normative Active as of 2025-12-13 | Computable Name: CP_4_5_Manage_Orders_for_Blood_Products_and_Other_Biologics

Communicate with appropriate sources or registries to manage orders for blood products or other biologics.

Description I:

Interact with a blood bank system or other source to support orders for blood products or other biologics including discontinuance orders. Use of such products in the provision of care is captured. Blood bank or other functionality that may come under jurisdictional law or other regulation (e.g., by the FDA in the United States) is not required; functional communication with such a system is required.

Criteria N:

CP.4.5#01 | SHALL | The system SHALL provide the ability to manage orders for blood products and biological products.
CP.4.5#02 | SHALL | The system SHALL provide the ability to manage the status (e.g., requisitioned, completed, in process) of blood product, and/or biological product orders.
CP.4.5#03 | SHALL | The system SHALL provide the ability to manage storage request orders for blood products, and/or biological products.
CP.4.5#04 | SHALL | The system SHALL provide the ability to manage the status of storage request orders (e.g., requisitioned, completed, in process) for blood products, and/or biological products.
CP.4.5#05 | SHALL | The system SHALL conform to function CPS.9.2 (Support for Inter-Provider Communication) to provide the ability to exchange blood product, and/or biological products between members of the care team.
CP.4.5#06 | SHALL | The system SHALL provide the ability to manage the use of blood products and other biologics in the provision of care.
CP.4.5#07 | SHOULD | The system SHOULD provide the ability to manage information associated with the collection and administration of non-blood biologics (e.g., breast milk products), including donor and recipient, and/or patient-identifying data, aliquot-identifying data, amount, route (e.g., oral versus tube), expiration date and time of administration.